Virus Antibody Testing Kalamazoo Mi

Lab Reagents

Human IgG antibody Laboratories manufactures the virus antibody testing kalamazoo mi reagents distributed by Genprice. The Virus Antibody Testing Kalamazoo Mi reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Virus products are available in stock. Specificity: Virus Category: Antibody Group: Testing Kalamazoo

Testing Kalamazoo information

MI-136

B6166-10 10 mg
EUR 373
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy.

MI-136

B6166-25 25 mg
EUR 757
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy.

MI-136

B6166-5 5 mg
EUR 232
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy.

MI-2

A3602-10 10 mg
EUR 282
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-200 200 mg
EUR 1558
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-5 5 mg
EUR 212
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-5.1 10 mM (in 1mL DMSO)
EUR 415
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-50 50 mg
EUR 630
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-3

A3603-10 10 mg
EUR 400
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3

A3603-100 100 mg
EUR 1553
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3

A3603-5 5 mg
EUR 267
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3

A3603-5.1 10 mM (in 1mL DMSO)
EUR 309
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-3

A3603-50 50 mg
EUR 1218
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription.

MI-192

C5851-10 10 mg
EUR 440
Description: MI-192 is a histone deacetylases (HDACs) inhibitor that preferentially inhibits HDAC2 and HDAC3 with IC50 values of 30 nM and 16 nM, respectively [1]. Histone acetylation is the most commonly employed mechanism utilized by transcription factors to activate gene expression.

MI-192

C5851-5 5 mg
EUR 270
Description: MI-192 is a histone deacetylases (HDACs) inhibitor that preferentially inhibits HDAC2 and HDAC3 with IC50 values of 30 nM and 16 nM, respectively [1]. Histone acetylation is the most commonly employed mechanism utilized by transcription factors to activate gene expression.

Human Mi-2 Antibody (Anti-Mi-2) ELISA Kit

abx052588-96tests 96 tests
EUR 668

MI-nc (hydrochloride)

B2816-1
EUR 142